REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

Clinical trial NCT07410117 · RECRUITING

Trial details

NCT number: NCT07410117
Sponsor: Regeneron Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cancer-Associated Thrombosis (CAT)

Start date: 2026-03-09
Primary completion: 2030-01-23
Enrollment: 1120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.